PACTR202006601935462
Not yet recruiting
未知
Promoting Adherence to Anti-retroviral Therapy and Viral suppression among HIV positive Young People in Uganda through Group Support Psychotherapy: Study Protocol for a Pilot Randomized Controlled Trial
CRI Foundation0 sites120 target enrollmentJune 2, 2020
ConditionsMental and Behavioural Disorders
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Mental and Behavioural Disorders
- Sponsor
- CRI Foundation
- Enrollment
- 120
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participant dyads must consist of an HIV seropositive young person (10\-18 years) with \=1000 viral copies/ml 6 months after initiating first\-line ART and a caregiver aged 19 years and older.
Exclusion Criteria
- •Participant dyads will be excluded if they have visual or hearing impairments, active untreated major mental illness (untreated psychosis or mania or high suicide risk) or severe medical conditions (active tuberculosis or pneumonia) that would interfere with participation in interventions
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Decision Making and Adherence to Antiretroviral Therapy in Patients Infected with Human Immunodeficiency Virus in Japan: Observational StudyHIV infectionJPRN-UMIN000030146Tokyo Medical University Department of Pharmacy225
Not yet recruiting
Not Applicable
Assessment Of Non-Adherence To Drugs Used In HIVHealth Condition 1: D50-D89- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanismCTRI/2021/07/034805Maulana Azad Medical College and associated Lok Nayak Hospitals
Completed
Not Applicable
Directly Observed antiretroviral Therapy for people living with Human Immunodeficiency Virus (HIV) and Acquired ImmunDeficiency Syndrome (AIDS): a randomised controlled trialISRCTN48682427Ministry of Health (Brazil)
Completed
Not Applicable
Continuous versus intermittent antiretroviral treatment among Human Immunodeficiency Virus (HIV)-infected individuals in a gold mining community in South AfricaHIV, Acquired Immunodeficiency Syndrome (AIDS)Infections and InfestationsHIVISRCTN52488382Medical Research Council (MRC) (UK)
Active, not recruiting
Phase 4
Investigating if switching HIV patients from stable combined antiretroviral therapy to Delstrigo has fewer unwanted side effects e.g. weight gain, while being just as effective at maintaining an undetectable HIV viral loadHuman immunodeficiency virus-1 (HIV-1)Infections and InfestationsHuman immunodeficiency virus [HIV] diseaseISRCTN42856592Chelsea and Westminster Hospital NHS Foundation Trust60